OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
April 02, 2022
The booming cell therapy market has created a need for capacity that outsourcing partners are ready to fill.
Meeting patient needs and achieving high quality are common goals for all stakeholders.
The continuous, aseptic fill/finish process is finding use in vaccines and biologic drugs.
April 01, 2022
Under the two-year task order, ATCC will continue to support the DCEG MEAS program in receiving, processing, storing, analyzing, and distributing clinical specimens from different cancer types.
March 18, 2022
Emmes has acquired Casimir, marking its fourth major acquisition.
March 08, 2022
What if we are underestimating China’s response to US/EU inshoring?
March 02, 2022
Scientists can work to overcome the challenges associated with protein characterization through empowering technologies.
Continuous improvements in technologies and services will help cold chain operators meet future industry demand.
Optimizing the use of partners for clinical trials depends on selecting the right contractor.
Capacity concerns and regulatory compliance considerations will drive the decision about outsourcing the manufacture of clinical trial materials.